PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming. Feng Y, Tang Y, Mao Y, Liu Y, et al. Int J Oncol 2020 Jan 10. doi: 10.3892/ijo.2020.4958.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Feng Y, Tang Y, Mao Y, Liu Y, et al. PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming. Int J Oncol 2020 Jan 10. doi: 10.3892/ijo.2020.4958.
PMID: 31922217